Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
 

Search in our Online Store

Small Molecules
Filter     Order     Display # 
Date Item Title
27 Apr 2006 Inspire Announces Initiation of Phase 2 Clinical Trial of Platelet Aggregation Inhibitor
27 Apr 2006 Array BioPharma Initiates Phase 1 Clinical Trial of Its MEK Inhibitor for Inflammatory Disease
27 Apr 2006 Two European Regulatory Milestones for Keppra
27 Apr 2006 Nihon Nohyaku Receives Approval for Lanoconazole, Antifungal Agent for Athlete's Foot
27 Apr 2006 Genaera Presents Evizon Overview And New Trodusquemine Data At Fortis Bank Biotechnology Conference
26 Apr 2006 CepTor Presents Statistically Significant Proof of Concept Data on Myodur for Muscular Dystrophy at the American Academy of Neurology Meeting
26 Apr 2006 EntreMed's Panzem(R) NCD Enters Clinical Trial in Metastatic Breast Cancer
26 Apr 2006 Independent Data Monitoring Board Recommends to Continue Satraplatin Phase 3 Trial as Planned
25 Apr 2006 NeoRx Expands Picoplatin Lung Cancer Clinical Trial Into Selected Eastern European Countries
25 Apr 2006 Debiopharm Presents Phase I Monthly Implant And Phase II Daily Oral Results Of ZT-1 For Alzheimer’s Disease
25 Apr 2006 DOV Pharmaceutical, Inc. Announces Results for the First Phase III Trial of Bicifadine in Chronic Pain
25 Apr 2006 Astex Therapeutics Announces IND Approval For Novel Cancer Drug AT9283
25 Apr 2006 Cephalon, Inc. Provides Update on Regulatory Status of SPARLON(TM)
25 Apr 2006 Pfizer Japan Obtains Approval for ZYVOX, Detrusitol, J Zoloft in Japan
24 Apr 2006 Researcher Reports Data on Effects of Posiphen(TM) on Human Neuronal Stem Cells; Posiphen May Support Stem Cell Transplantation in Alzheimer's Disease
24 Apr 2006 Neurochem presents an update on tramiprosate (Alzhemed(TM))
22 Apr 2006 Progenics Pharmaceuticals and Wyeth Announce Plan to File NDA for Subcutaneous Methylnaltrexone in an Improved Formulation
21 Apr 2006 Astellas Pharma Obtains Approval for Funguard and Vesicare
21 Apr 2006 Shionogi, Nippon Kayaku Receive Approval for Cetrotide
21 Apr 2006 Dainippon Sumitomo Pharma Receives Approval for Antifungal Agent AmBisome
21 Apr 2006 Novartis Pharma Obtains Additional Approval for Osteoclastic Inhibitor Zometa
21 Apr 2006 GTx, Inc. Announces Initiation of Phase IIIb Extension Trial of Acapodene for the Treatment of Side Effects of Androgen Deprivation Therapy
21 Apr 2006 FOSRENOL® significantly reduces tablet burden for ESRD patients with hyperphosphatemia and improves patient and physician satisfaction, a new study reports
21 Apr 2006 Theravance Announces Initiation of Phase 2b Clinical Program with Investigational Long-Acting Beta Agonist in Beyond Advair Collaboration
21 Apr 2006 Japan Tobacco, GlaxoSmithKline Conclude Licensing Agreement for New Drug Candidate
21 Apr 2006 Æterna Zentaris Gains Market Approval for Cetrotide® (cetrorelix) in Japan for In Vitro Fertilization
21 Apr 2006 POZEN Announces Completion of Special Protocol Assessment for PN 200; New Arthritis Product Phase III Trials to Begin on Schedule
20 Apr 2006 Endocyte begins Phase 1 trial of EC145 for treatment of refractory solid tumors
20 Apr 2006 Ilypsa Completes Phase 1 Clinical Trial of ILY101 for Hyperphosphatemia Associated with Chronic Kidney Disease
20 Apr 2006 Acuity Pharmaceuticals Continues Pipeline Expansion By Licensing a Novel Broad Spectrum Anti-Infective for Ophthalmic Use
20 Apr 2006 Rockwell Medical Technologies, Inc. Submits SFP Pre-IND Package Containing Phase III Clinical Protocol to FDA
20 Apr 2006 Alexza Initiates AZ-002 Phase IIa Clinical Trial in Patients With Panic Disorder
20 Apr 2006 Schering-Plough Provides Update on Oral HCV Protease Inhibitor SCH 503034 Clinical Development Program for Hepatitis C
20 Apr 2006 New drug application for Rasilez, an innovative oral renin inhibitor to treat high blood pressure, accepted for US regulatory review
20 Apr 2006 FDA Grants Fast Track Designation to Schering-Plough for its Thrombin Receptor Antagonist SCH 530348
20 Apr 2006 Meditor Pharmaceuticals Initiates Phase II Trial for Intradialytic Hypotension
19 Apr 2006 BioSante Pharmaceuticals Announces FDA Filing and Review of NDA for Bio-E-Gel
19 Apr 2006 Predix Announces Preliminary Results from Phase Ib Trial of PRX-08066 in Hypoxia-Induced Pulmonary Hypertension
19 Apr 2006 Anacor Interim Phase 2 Study Results Show AN2690 Penetrates Nail Bed, Kills Fungi to Successfully Treat Nail Infections
19 Apr 2006 ACADIA Pharmaceuticals Announces Positive Clinical Trial Results Demonstrating That ACP-103 Increases Slow Wave Sleep
19 Apr 2006 Millennium and Johnson & Johnson Pharmaceutical Research and Development Initiate Phase III Clinical Trial with VELCADE(R) (bortezomib) for Injection in Follicular Non-Hodgkin's Lymphoma
19 Apr 2006 European Commission Grants Orphan Medicinal Product Designation to Nexavar for the Treatment of Hepatocellular Carcinoma
19 Apr 2006 CombinatoRx Reports Positive Results for CRx-170 in Phase 2 Proof-of-Concept Asthma Clinical Trial; Novel Combination Drug Candidate Demonstrates Clinical Benefit on Forced Expiratory Volume (FEV1)
19 Apr 2006 Neurochem announces eprodisate (Fibrillex™) NDA filed and granted priority review by the FDA for the treatment of AA amyloidosis
19 Apr 2006 MGI PHARMA Announces Publication of Phase 3 Data for Dacogen(TM) (Decitabine) for Injection in Cancer
18 Apr 2006 OSI Pharmaceuticals Announces Submission of New Drug Application for Tarceva(R) in Japan
18 Apr 2006 Cytokinetics Announces the Initiation of Phase I/II Clinical Trial for SB-743921
18 Apr 2006 Dainippon Sumitomo Pharma and Eisai Signed Licensing Agreement for "Gasmotin(R)", a Gastroprokinetic Agent, for Countries in Asia including ASEAN Members
14 Apr 2006 GlaxoSmithKline and Adolor announce the completion of enrolment of pivotal clinical studies of Entereg (alvimopan)
14 Apr 2006 Alkermes and Cephalon Receive FDA Approval of Vivitrol™ for the Treatment of Alcohol Dependence
 
<< Start < Prev 101 102 103 104 105 106 107 108 109 110 Next > End >>
Results 5201 - 5250 of 5705

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics